| CASE REPORT |
|
| Year : 2012 | Volume
: 3
| Issue : 2 | Page : 196-199 |
|
|
Ethionamide-induced gynecomastia
Ramakant Dixit1, Jacob George1, Arun K Sharma2, Naveen chhabra2, Suresh K Jangir1, Vikas Mishra1
1 Department of Respiratory Medicine, J. L. N. Medical College, Ajmer, India
2 Department of Pharmacology and Experimental Therapeutics, J. L. N. Medical College, Ajmer, India
Correspondence Address:
Ramakant Dixit
A-60, Chandravardai Nagar, Ajmer - 305 001, Rajasthan
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0976-500X.95532
|
|
|
Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
